Tìm theo
XTL-6865
Thuốc Gốc
Small Molecule
XTL-6865 is a combination of two fully human monoclonal antibodies (Ab68 and Ab65) against the hepatitis C virus E2 envelope protein. It is being developed to prevent HCV re-infection following a liver transplant and for the treatment of chronic HCV disease.
Cơ Chế Tác Dụng : XTL-6865 is a combination of two fully human monoclonal antibodies (Ab68 and Ab65) against the hepatitis C virus E2 envelope protein. It is being developed to prevent HCV re-infection following a liver transplant and for the treatment of chronic HCV disease. XTL-6865 is a dual-antibody (Ab68 and Ab65) therapy directed against the highly mutagenic hepatitis C E2 envelope protein and intended therefore to inhibit viral entry into host cells.
Chỉ Định : Investigated for use/treatment in hepatitis (viral, C).
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB06058
... loading
... loading